Overview
Liliana Pinho practices practicing medicine in Porto, Portugal.
Her clinical expertise encompasses Congenital Toxoplasmosis, Primary Amebic Meningoencephalitis, and Stroke.
She is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Liliana Pinho
Is Liliana Pinho a top-rated expert for Congenital Toxoplasmosis?
MediFind is an objective health platform that identifies experts based on real-world data. Liliana Pinho is classified as an Experienced expert for Congenital Toxoplasmosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Liliana Pinho participate in research or clinical trials?
Yes. Liliana Pinho has published 13 articles and abstracts on conditions like Congenital Toxoplasmosis. You can view a list of Liliana Pinho's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Congenital ToxoplasmosisMs. Pinho isExperienced. Learn about Congenital Toxoplasmosis.
- Primary Amebic MeningoencephalitisMs. Pinho isExperienced. Learn about Primary Amebic Meningoencephalitis.
- StrokeMs. Pinho isExperienced. Learn about Stroke.